Progressive substitution of fish oil with Schizochytrium-derived algal oil in the diet of Atlantic salmon (Salmo salar) parr subjected to winter signal period

The aim of this study was to investigate the impact of progressive replacement of fish oil with Schizochytrium-derived oil from Veramaris® (VMO) in the diets of Atlantic salmon, focusing on its effect during the pre-adaptation to smoltification phase of parr, with an emphasis on the winter signal period. Substitution of fish oil with VMO during this critical developmental phase of salmon (pre-adaptation to smoltification phase) can contribute to the goal of reducing dependence on wild fisheries as a primary source of essential fatty acids in aquafeeds. Three isoproteic, isolipidic and isoenergetic diets were formulated; a control diet containing 5% fish oil and 12% plant oil (0VMO) and two other diets, in which 50% and 100% of the EPA+DHA from fish oil were replaced with VMO, henceforth referred to as 50VMO and 100VMO, respectively. The fish were exposed to a 12 L:12D photoperiod over a 49-day window with samples collected at five time points, including a 48-h salt water challenge to evaluate the effects on common smoltification-related biomarkers including the expression of two genes coding for the two protein isoforms of the NKA alpha catalytic subunit (nkaa1a, nkaa1b), the gene coding for NA+/K+Cl⁻ co-transporter (nkcc1) in the gills as well as osmolality, Cl-, Mg2+, Ca2+, cortisol, growth hormone, and insulin-like growth factor-1 in plasma. The results showed non-significant differences in growth performance and only minor differences in smoltification-related parameters between the dietary treatment groups. Overall, the unconventional source of EPA+DHA was not detrimental to growth, hypoosmoregulatory ability or general welfare, suggesting that the progressive substitution of fish oil with Schizochytrium-derived oil in diets for Atlantic salmon parr is a viable option for adoption by the aquaculture industry.